These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1345 related items for PubMed ID: 2841426

  • 21. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons.
    Tompkins MM, Basgall EJ, Zamrini E, Hill WD.
    Am J Pathol; 1997 Jan; 150(1):119-31. PubMed ID: 9006329
    [Abstract] [Full Text] [Related]

  • 22. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE, Daniel SE, Sangha H, Eisen S, Lees AJ, Foster OJ.
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [Abstract] [Full Text] [Related]

  • 23. Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease.
    Jenner P.
    Acta Neurol Scand Suppl; 1993 Feb; 146():6-13. PubMed ID: 8333254
    [Abstract] [Full Text] [Related]

  • 24. Relationships between Lewy bodies and pale bodies in Parkinson's disease.
    Dale GE, Probst A, Luthert P, Martin J, Anderton BH, Leigh PN.
    Acta Neuropathol; 1992 Feb; 83(5):525-9. PubMed ID: 1320323
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Stability of cell size and nucleolar size in Lewy body containing neurons of substantia nigra in Parkinson's disease.
    Gertz HJ, Siegers A, Kuchinke J.
    Brain Res; 1994 Feb 21; 637(1-2):339-41. PubMed ID: 8180816
    [Abstract] [Full Text] [Related]

  • 28. Cell death mechanisms in Parkinson's disease.
    Jellinger KA.
    J Neural Transm (Vienna); 2000 Feb 21; 107(1):1-29. PubMed ID: 10809400
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Epitopes located in spatially separate domains of each neurofilament subunit are present in Parkinson's disease Lewy bodies.
    Hill WD, Lee VM, Hurtig HI, Murray JM, Trojanowski JQ.
    J Comp Neurol; 1991 Jul 01; 309(1):150-60. PubMed ID: 1716646
    [Abstract] [Full Text] [Related]

  • 34. Marinesco bodies and substantia nigra neuron density in Parkinson's disease.
    Abbott RD, Nelson JS, Ross GW, Uyehara-Lock JH, Tanner CM, Masaki KH, Launer LJ, White LR, Petrovitch H.
    Neuropathol Appl Neurobiol; 2017 Dec 01; 43(7):621-630. PubMed ID: 28626918
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry.
    Lennox G, Lowe J, Landon M, Byrne EJ, Mayer RJ, Godwin-Austen RB.
    J Neurol Neurosurg Psychiatry; 1989 Nov 01; 52(11):1236-47. PubMed ID: 2556498
    [Abstract] [Full Text] [Related]

  • 38. [Morphochemical changes in the substantia nigra cellular structures in Parkinson's disease].
    Salkov VN, Khudoerkov RM, Voronkov DN, Sobolev VB, Kutukova KA.
    Arkh Patol; 2017 Nov 01; 79(5):3-9. PubMed ID: 29027522
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Alzheimer's disease with widespread presence of Lewy bodies.
    Mitsuyama Y, Fukunaga H, Yamashita M.
    Folia Psychiatr Neurol Jpn; 1984 Nov 01; 38(1):81-8. PubMed ID: 6100367
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 68.